Search research articles
Contact Us
Filters
Showing results (41-50 of 539) with videos related to
Page
of 54
Sort By:
Leukemia & Lymphoma
|
April 10, 2008
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma
Christian Frank, Michael Hundemer, Anthony D Ho, et al.
Annals of Hematology
|
June 24, 2023
Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis
Rea Kuehl, Maximilian Koeppel, Hartmut Goldschmidt, et al.
Psycho-Oncology
|
April 12, 2013
Psychosocial support in patients with multiple myeloma at time of diagnosis: who wants what?
Jette Lamers, Mechthild Hartmann, Hartmut Goldschmidt, et al.
Hematological Oncology
|
August 26, 2017
Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case-based approach
Marc-Andrea Baertsch, Michael Hundemer, Jens Hillengass, et al.
Annals of Hematology
|
June 30, 2014
Extramedullary relapse after accidental head injury in a patient with multiple myeloma
Maximilian Merz, Leonille Schweizer, Modar Kentar, et al.
Deutsches Arzteblatt International
|
March 22, 2022
Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance
Vanessa Piechotta, Nicole Skoetz, Monika Engelhardt, et al.
British Journal of Haematology
|
November 15, 2013
DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine
Jerome Moreaux, Angelique Bruyer, Jean-Luc Veyrune, et al.
Cancer Treatment Reviews
|
May 22, 2012
Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment
Meletios A Dimopoulos, Evangelos Terpos, Hartmut Goldschmidt, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2017
Quantitative analysis of <sup>18</sup>F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma
Christos Sachpekidis, Jens Hillengass, Hartmut Goldschmidt, et al.
Annals of Hematology
|
September 22, 2010
Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment
Ulrike Klein, Kai Neben, Thomas Hielscher, et al.
Page
of 54
Search research articles
Search
Showing results (41-50 of 539) with videos related to
Sort By:
Page
of 54
Leukemia & Lymphoma
|
April 10, 2008
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma
Christian Frank, Michael Hundemer, Anthony D Ho, et al.
Annals of Hematology
|
June 24, 2023
Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis
Rea Kuehl, Maximilian Koeppel, Hartmut Goldschmidt, et al.
Psycho-Oncology
|
April 12, 2013
Psychosocial support in patients with multiple myeloma at time of diagnosis: who wants what?
Jette Lamers, Mechthild Hartmann, Hartmut Goldschmidt, et al.
Hematological Oncology
|
August 26, 2017
Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case-based approach
Marc-Andrea Baertsch, Michael Hundemer, Jens Hillengass, et al.
Annals of Hematology
|
June 30, 2014
Extramedullary relapse after accidental head injury in a patient with multiple myeloma
Maximilian Merz, Leonille Schweizer, Modar Kentar, et al.
Deutsches Arzteblatt International
|
March 22, 2022
Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance
Vanessa Piechotta, Nicole Skoetz, Monika Engelhardt, et al.
British Journal of Haematology
|
November 15, 2013
DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine
Jerome Moreaux, Angelique Bruyer, Jean-Luc Veyrune, et al.
Cancer Treatment Reviews
|
May 22, 2012
Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment
Meletios A Dimopoulos, Evangelos Terpos, Hartmut Goldschmidt, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2017
Quantitative analysis of <sup>18</sup>F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma
Christos Sachpekidis, Jens Hillengass, Hartmut Goldschmidt, et al.
Annals of Hematology
|
September 22, 2010
Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment
Ulrike Klein, Kai Neben, Thomas Hielscher, et al.
Page
of 54